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Proliferative Lesions of the Glandular
Stomach and Liver in F344 Rats Fed Diets
Containing Aroclor 1254
by Jerrold M. Ward*
Aroclor 1254 was fed to groups of 24 male and 24 female F344 rats, from 7 weeks of age, at dietary
concentrations of 25, 50 and 100 ppm for up to 105 weeks. There was a dose-related depression of body
weight gain for both sexes and decrease in survival for male rats. Histologically, an increased incidence
of gastric intestinal metaplasia and adenocarcinoma was found in both sexes. Hepatocellular adenomas,
carcinomas, and eosinophilic and vacuolated hepatocellular foci were usually found in dosed rats only.
The number of these foci per unit area of liver was significantly increased in dosed rats, although eosi-
nophilic foci were only found in rats exposed to Aroclor 1254. Basophilic hepatocellular foci were found
in similar numbers per square centimeter of liver in controls and treated rats. This finding suggested that
eosinophilic hepatocellular foci and tumors arose de novo rather than from the naturally occurring ba-
sophilic foci. The appearance of unique, potentially preneoplastic lesions and tumors in the liver and
stomach in dosed rats which do not usually occur spontaneously in control rats would support the hy-
pothesis that Aroclor 1254 induced or initiated these unique lesions de novo rather than promoted the
growth of any naturally occurring lesions. Nonneoplastic hepatic lesions included degenerative hepato-
cellular changes and aggregates of macrophages with crystalline cytoplasmic structures and pigment
granules.
Introduction
Polychlorinated biphenyls (PCBs) have been shown
to induce liver tumors in rats (1-5) and mice (6-8) and
to promote development of liver preneoplastic foci and
tumors initiated by other carcinogens in liver (9-19). In
the early 1970s, little was known of the carcinogenic
potential ofPCBs. The National Cancer Institute's for-
mer bioassay program selected Aroclor 1254 for testing
for carcinogenicity in a large scale experiment to study
the effects ofcombinations ofchemicals. This large study
of approximately 24,000 F344 rats was conducted at
Stanford Research Institute under contract to the Na-
tional Cancer Institute and was completed in 1974. This
paper reviews the previous findings ofthe Aroclor 1254
bioassay (4) and re-evaluates hepatic and gastric lesions
in light of recent cancer research finding.
Methods
Weanling male and female F344 rats were obtained
from Simonsen Laboratory (Gilroy, CA) and from 7
*Tmor Pathology and Pathogenesis Section, Laboratory of Com-
parative Carcinogenesis, Division of Cancer Etiology, National Can-
cer Institute, Frederick, MD 21701.
weeks of age were fed a diet (Ralston Purina Co., St.
Louis, MO) which contained 0, 25, 50 or 100 ppm of
Aroclor 1254 (Monsanto Chemical Co., St. Louis, MO)
for 105 weeks (Table 1) (4). The Aroclor 1254 was ana-
lyzed at SRI and found to be composed of54.67% chlor-
ine and to be a mixture ofat least 18 isomers with from
4 to 7 chlorine atoms per molecule. The test chemical
was dissolved in corn oil for addition to the diet.
A complete necropsy was performed on each rat in
the experiment. Histopathologic slides were prepared
Table 1. Design of Aroclor 1254 chronic feeding studies in rats.
Sex and Initial Aroclor 1254
treatment no. of in diet, Time on study, weeks
group animalsa ppb Treated Untreated
Males
Matched control 24 0 105
Low dose 24 25 105
Intermediate dose 24 50 105
High dose 24 100 105
Females
Matched control 24 0 105
Low dose 24 25 104-105
Intermediate dose 24 50 104-105
High dose 24 100 105
aR]j animals were 53 ± 2 days of age when placed on study
bAll diets contained 3% corn oil.J. M. WARD
from all gross lesions, lungs, spleen, liver, testes,
pituitary, kidney and brain. Generally, only one section
of liver was prepared. In the original bioassay, few
sections ofthe stomach were evaluated. In asubsequent
review of the study, all stomachs were sectioned (20).
Sections were stained with hematoxylin and eosin.
Selected sections were stained by one of the following
methods: periodic acid-Schiff method (PAS), Wilder's
reticulin, Masson's trichrome, Alcian Blue-PAS. All
liver sections from the study were reviewed by the
authorinAugustof1983. Hepaticlesions were classified
according to Ward (21,22).
For quantitation of focal proliferative liver lesions,
the area of each liver section was determined using an
automated image analyzer (Videoplan, Carl Zeiss, Inc.,
New York, NY). The number and type of foci and
nodules were recorded and the number of foci per
square centimeter was determined for each rat (22).
The Mann-Whitney (Wilcoxon) test (23) was used to
determine the significance ofdifferences ofthe number
of foci between groups. For analysis of liver tumor
incidence, Fisher's exacttestandtheCochran-Armitage
test for trend were used (24).
Results
Clinical Signs, Body Weights, and
Survival
There was a dose-related depression ofbody weight
gain for both sexes, which persisted from week 10 until
the end of the bioassay. Survival was dose-related for
malesbut notforfemales: 92% ofthe controlmales, 83%
ofthe low dose, 58% ofthe intermediate dose, and 46%
ofthe high dose males survived to the end ofthe bioas-
say. The contributing causes of death for 13 male rats
receiving the highest dose included leukemia (5), pneu-
monia (2), hepatic lesions (6), intestinal carcinoma (1),
liver carcinoma (1) and brain abscess (1). For 10 males
at the intermediate dose, the contributing causes ofdeath
included leukemia (4), pneumonia (6) and intestinal car-
cinoma(1). Inseveral cases, more than one contributing
cause of death was found. In some cases, the cause of
earlymortalityofthemales mayhavebeenAroclor 1254
exposure (4) (hepatic lesions, intestinal carcinoma and
liver carcinoma) while in other cases, natural causes
were evident (leukemia and pneumonia). The Aroclor
1254 may have accentuated the natural deaths through
immunosuppressive or other mechanisms.
Pathology
Many types of neoplastic and nonneoplastic lesions
were found in rats in all groups. Except for those in the
liver, stomach and intestine, no lesions were related to
the administration of Aroclor 1254 (4).
Hepatic Lesions
The numbers and types of hepatic lesions were
significantly related to the administration of Aroclor
1254 (Table 2). Focal hyperplasias (foci of cellular
alteration) of the eosinophilic type were found only in
rats given Aroclor 1254 (Table 2). Hepatocytes in these
foci were larger than normal hepatocytes and had
prominent pale eosinophilic cytoplasm (Figs. 1 and 2).
They occurred randomly in the hepatic lobule and were
multiple in many dosed rats. Some foci were 5 to 10 cells
in diameter while others were larger than a lobule.
When compression was found on two sides ofthe focus,
the lesions were diagnosed as hepatocellular adenoma.
Adenomas were usually large lesions, 1 to 5 mm in size.
As in the eosinophilic foci, the hepatocytes in eosino-
philic adenomas were larger than normal hepatocytes
Table 2. Hepatocellular foci and tumors in groups of 24 F344 rats fed diets containing Aroclor 1254.
Hepatocellular
Hepatocellular foci/cm2± SD adenoma (number with lesion) Any
Dose, Basophilic Eosino- Baso- Vacou- Carci- liver
ppm Sex Eosinophilic (% with lesion) Vacuolated philic philic lated noma tumor
0 Male 0 1.48 ± 3.75 0 0 0 0 0 0
( 0) (29) (0)
25 Male 0.93 ± 1.82* 0.27 ± 1.03 0.60 ± 1.80 1 0 0 0 1
(29)t (8) (16)
50 Male 0.76 ± 1.29 0.63 ± 1.70 0.58 ± 1.70 2 0 0 0 2
(33)t (16) (16)
100 Male 1.24 ± 2.84* 1.58 ± 3.24 0.41 ± 0.66 3 1 1 2 7*
(43)t (37) (29)t
0 Female 0 1.15 ± 3.30 0.09 ± 0.45 0 0 0 0 0
(0) (29) (4)
25 Female 2.74 ± 3.86 0.44 ± 0.92 0.04 ± 0.21 0 0 0 0 0
(54)t (20) (4)
50 Female 3.34 ± 3.49t 0.15 ± 0.73 0.10 ± 0.50 3 0 0 0 3
(62)t (4) (4)
100 Female 1.27 ± 2.30* 0.87 ± 2.31 1.07 ± 1.62* 1 0 1 0 2
(41)t (29) (41)t
*<0.05 as compared with appropriate control.
t<0.01 as compared with appropriate control.
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FIGURE 2. Higher magnification of Fig. 2, showing large hepato- FIGURE 1. Eosinophilic focus (arrows) in liver of female F344 rat cytes in focus with prominent eosinophilic cytoplasm containing fed diet containing 100 ppm of Aroclor 1254. H & E; x54* basophilic bodies. Note dark rounded hepatocytes in adjacent areas.
H & E: x220)
and had eosinophilic cytoplasm (Fig. 3). Seven adeno-
mas were found in males and four in females. One male
given the high dose and one female given the intermedi-
ate dose of Aroclor 1254 each had two eosinophilic
adenomas. Hepatocellular carcinomas in two male rats
receiving the highest dose of Aroclor 1254 were also
composed predominantly of eosinophilic hepatocytes.
Areas ofprominent trabecular formations were seen in
tumors of both rats and vascular invasion was seen in
one tumor.
Basophilic foci were found both in control and in
dosed rats (Fig. 4). They were not clearly dose-related.
These foci were similar to those found in normal aging
F344 rats. One basophilic adenoma was found in a high
dose male rat. Focal areas of lipidosis (Fig. 5) were
found primarily in dosed males and in dosed females.
Two adenomas were composed of hepatocytes with
prominent lipid droplets. When all types ofliver adeno-
mas and carcinomas were combined there was a dose-
related trend in tumorincidence (p < 0.01) in male rats.
Other types of hepatic lesions were found (Table 3).
Large granular lymphocyte (LGL) leukemia was dose
related in males (control 3/24, low dose 2/24, interme-
diate dose 5/24, high dose8/24) but notinfemales. Gran-
ulomas (composed of histiocytes and lymphocytes) in
portal areas ofthe liverwere sometimes associated with
pigmented macrophages, but the former lesions were
also seen incontrols aswell. Clusters ofpigmented mac-
FIGURE 3. Portion of eosinophilic hepatocellular adenoma (arrows)
in male rat receiving diet containing 100 ppm of Aroclor 1254.
Note large size of cells as compared with normal hepatocytes. H
& E; x200.
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rophages having crystalline structures within their cy-
toplasmwere observed indosed rats only(Fig. 5). More
lesions with macrophages were found in females than
in males.
Mild to moderate degenerative changes of hepato-
cytes occurred in a dose-related distribution. In high
-P -qwz ''s -M. "'OVA :-.Z ,,_ fmt il* s T f _d'wae~ .=.% -
cytoplasm (baso-
dose rats, hepatocytes were variable in size and individ-
ual cells were rounded. Foci ofbile duct hyperplasia and
oval cell (cholangiocellular) hyperplasia were seen in a
fewhigh dose rats. Oval cell hyperplasia was sometimes
associated with eosinophilic foci.
Gastric Lesions
Intestinal metaplasia and gastric adenocarcinoma
were found in association with the feeding of Aroclor
1254 (Table 4). Because the necropsy protocol was not
designed to detect gastric lesions, the actual incidence
ofthese lesions may be higher. Three control rats (two
males, one female) had small metaplastic lesions in
association with lymphoid follicles in the pyloric region
of the glandular stomach. The metaplastic lesions in
dosed rats were different than those in the controls.
Metaplasia was seen as the presence of many mucin-
containing epithelial cells (Fig. 6). The lesions were
usually not associated with lymphoid follicles and were
Table 3. Incidence of other hepatic lesions.
No. of rats with lesion/no. of rats in group (%)
Pigmented
macrophages
with crystalline
Dose Sex LGL leukemia Granulomas structures
0 Male 3/24 (12.5) 4/24 (16.6) 0/24 (0)
25 Male 4/24 (16.6) 0/24 (0) 0/24 (0)
50 Male 6/24 (25.0) 4/24 (16.6) 4/24 (16.6)
100 Male 7/24 (29.1) 2/24 (8.3) 5/24 (20.8)*
0 Female 4/24 (16.6) 12/24 (50.0) 2/24 (8.3)
25 Female 7/24 (29.1) 6/24 (25.0) 7/24 (29.1)*
50 Female 7/24 (29.1) 8/24 (33.0) 16/24 (66.6)t
100 Female 4/24 (16.6) 11/24 (45.8) 23/24 (95.8)t
*p < 0.05.
tp <0.01.
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FIGURE 5. Two clusters of macrophages (m) with crystalline inclusions in liver of female rat fed Aroclor 1254. H & E; x 330.
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Table 4. Intestinal metaplasia and gastric adenocarcinoma in
male and female F344 rats fed Aroclor 1254.
No. of rats with lesion/
no. of rats treated
Dietary concentration Intestinal
of Aroclor 1254, ppm metaplasia Adenocarcinoma
0 3/47 0/47
25 4/48 1/48
50 5/48 3/48
100 15/48* 2/48
p < 0.05 as compared with control group.
FIGURE 7. Intestinal metaplasia in rat showing focal cystic lesion
with reactive inflammation. H & E; x54.
FIGURE 6. Intestinal metaplasia in glandular stomach showing mu-
cin in lesions (arrows) and none in adjacent normal epithelium.
Alcian Blue-PAS; x 130.
frequently cystic (Fig. 7). The epithelium had areas
containing mucus and was composed of single layers of
basal, goblet or tall columnar cells. None of these
lesions were apparent grossly at necropsy. Adenocarci-
nomas were usually seen at necropsy and invaded the
stomach wall to varying degrees. Some tumors were
cystic, and similar in morphology to the metaplastic
lesions, except for piling up of multiple layers of
epithelial cells (Fig. 8), increased anaplasia and invasion
(Fig. 9).
Discussion
The bioassay of Aroclor 1254 in F344 rats provided
evidence for the induction ofproliferative lesions ofthe
FIGURE 8. Portion of invasive gastric adenocarcinoma with single
layered and multiple layered epithelium and loss ofepithelial cell
polarity. H & E; x330.
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FIGURE 9. Portion of large gastric adenocarcinoma with early in-
vasion into submucosa (arrow). H & E; x80.
liver and stomach by the chemical. The evidence con-
sists ofunusual morphological lesions in rats exposed to
Aroclor 1254. The low incidence ofsome ofthese lesions
may depend, in part, on the dosages used in the study
Although body weight depression was adequate for a
chronic bioassay, hepatic lesions were not as severe as
one might expect from a liver toxin, even in other
studies with PCBs (24,25). In another rat bioassay of
Aroclor 1254 with dosesupto 1000ppm, no livertumors
were seen in the 8-month study (26). In mice given 300
ppm in the diet, liver tumors and adenofibrosis were
seen (7). In studies of other polychlorinated biphenyls,
livertumors were found when dietary levels offrom 100
to 1000 ppm were used (1-5).
Eosinophilic hepatocellular foci, like those found in
this study, were also seenin anotherbioassay ofAroclor
1260 (2). The eosinophilic foci could be precursors of
eosinophilic adenomas and carcinomas. Other chemicals
have caused these unusual liver lesions. Eosinophilic
foci and adenomas were seen in rats exposed to pheno-
barbital only (22) or after initiation by diethylnitro-
samine and promotion by phenobarbital (J. Ward,
unpublished observations). Since the foci in control
F344 rats were basophilic (21,22) and foci in rats
exposed to Aroclor 1254 were eosinophilic, the chemical
may have induced these foci de novo ortransformed the
spontaneous basophilic foci to eosinophilic lesions. The
fact that numbers of basophilic foci were similar in
control and treated rats suggests that the eosinophilic
foci were formed de novo or arose from other types of
foci not readily visible or reported. Vacuolated or clear
cell foci have been reported in aging F344 rats but are
difficult to detect (22). Polychlorinated biphenyls were
shown to be promoters ofliver foci and tumors in short
term in vivo assays (9-19). The findings in this study
suggest that they may also be initiators. It has been
suggested that nongenotoxic promoters would promote
spontaneous foci ratherthan initiate new tumor popula-
tions (27,28). Aroclor 1254, like phenobarbital, induces
the eosinophilic foci and tumors rather than promoting
the spontaneous basophilic lesions. Both carcinogens
may act directly onhepatocytes to cause proliferation of
smooth endoplasmic reticulum, an effect which causes
affected hepatocyte cytoplasm to appear eosinophilic
(26).
Stomach lesions in F344 rats exposed to Aroclor 1254
werethoseofintestinalmetaplasiaandadenocarcinoma.
We previously showed these lesions to contain alkaline
phosphatase (20). The metaplastic lesions resembled
those in monkeys exposed to PCB (29,30), but differed
fromthemin some characteristics. Monkey lesions were
diffuse while rat lesions were focal and usually singular.
Stomach tumors were notfound inmonkeys. Thefinding
ofthe unusual metaplastic lesions in rats suggests that
Aroclor 1254 acted as an initiating agent rather than as
a promoting agent, since the few metaplastic lesions in
stomachs of control rats differed morphologically from
those in dosed rats. The metaplastic lesions resembled
precancerous lesions induced by gastric carcinogens
(31), but the few invasive tumors seen suggest further
study is needed ofthe effect ofPCBs on the glandular
stomach of rats.
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